Skip to content
Search

Latest Stories

‘Dance represents life and is a mirror to our experiences'

BRITISH MAESTRO AAKASH ODEDRA ON LIFE IN LOCKDOWN AND HIS NEW SHOW

by ASJAD NAZIR


THE last decade has been quite extraordinary for acclaimed British dancer Aakash Odedra.

The fabulously fleet-footed talent has gone from superb shows like his full-length solo debut Rising to setting up a dynamic company that has delivered exciting work and helped expand the horizons of classical Indian dance. The rapid rise has enabled him to perform all over the world, light up major venues and collaborate with artistic giants.

The widely acclaimed dancer and choreographer was due to carry on that impressive momentum in 2020 with thrilling new show Samsara, but one of the year’s most highly anticipated tours was halted by the Covid-19 virus.

So, while he may fly like a free bird onstage, the classically trained dancer has had his wings clipped by the pandemic like the rest of the world and has been stuck indoors. But it hasn’t stopped him from learning more about himself.

Eastern Eye caught up with Aakash Odedra to talk about his thrilling journey as a performer, his stunning-looking new show Samsara, the unique way in which he has spent lockdown and future hopes.

How do you look back on your journey in dance?

It depends on which point of my life I focus on. My journey ‘officially’ spans 28 years and, in that time, I have been pushed and pulled by the currents of the ocean. Sometimes I have been washed ashore on uncharted territories, other times I have landed on familiar ground. The further my boat sails, the more knowledge and understanding I have when I look back on my past. Each story seems to progress more with time, some chapters open and close, others urge me to search deeper within.

How much has lockdown disrupted your plans?

Every disruption is an indication of the good to come. After being on a hamster wheel for the last 12 years, I welcomed the abrupt stop. As an artist, I feel we have a natural synchronicity with nature and it’s evident that we are being urged to stop and re-evaluate. I think we all have to recalibrate and realign ourselves with a new state of mind.

What have you been doing?

Lockdown gave me the opportunity to go into deep meditation to find answers for questions I have been asking myself for a while now. I locked myself in my room with no food or water, sitting in one place for three days, meditating. The process of observation, the chance to trace the path of my thoughts back to their origin, was remarkable. For me, I realised that it’s not lockdown that has been disruptive. Rather, we have disrupted our own inner patterns and thoughts through unnecessary desires, focusing on what we want rather than what we need.

What have you been doing during lockdown in terms of dance?

Nothing! I have hardly danced and taken the opportunity to rejuvenate, mentally and spiritually. I have found creative expression in watching a seedling grow in the garden and blossom. That doesn’t mean my participation has been passive, on the contrary, I’ve been actively observant. The time has come for me to invent new rules and new pathways, not to retread old roads. For me, dance represents life; it’s a mirror to all our experiences, a reflection of honesty, fragility and humanity. We can’t expect to speak to the world about life if we have become ignorant of it or are too self-absorbed in rehearsals or emails. By nourishing the soul and mind, we can organically reset ourselves. Change doesn’t need to be revolutionary and can be like a minute whisper that carries its message on the wind.

How much of a disappointment is it that you could not premiere your latest work Samsara?

If I have learnt anything in the last few months, it’s to expect the unexpected, or even better, don’t expect anything at all. For me, it was an achievement and a miracle that Samsara premiered at the Asia TOPA Festival in Melbourne. We suffered greatly as a company during the build-up because my fellow performer, Hu Shenyuan, was Chinese. The world started locking its borders; we had to move swiftly and didn’t know if it would be possible for him to be part of the production that we had worked on together for three years. In the end, we premiered it with Hu against all the odds. The experience was priceless, not disappointing.

When can we expect to see Samsara?

It’s a waiting game – but a game for which I hold no expectations.

Tell us something about your new work?

Samsara, inspired by the classic Chinese novel Journey to the West, traces the steps we take, both forward and backward, in search of our higher selves. It’s an epic, highly visual, mythological story. It draws on the thinking and imagery at the heart of Buddhist philosophy and explores some of the 81 obstacles and six states of mind that can hold us back.

What inspired this new piece?

The story of Journey to the West, a monk who took 14 years to walk from China to India to find original Buddhist scriptures and knowledge, became the key point of interest for us. We were fascinated to think that hundreds of years ago there was a need for cultural interdependency to further one’s own civilisation and understanding. It’s ironic that today, when we have easy access to transport, the nations’ walls seem to be getting higher and higher, and the thirst for learning about other cultures seems to be rapidly diminishing with time.

What is the dance master plan going forward?

I don’t make master plans! I let the plans make me.

You have achieved a lot in a short space of time, but do you have one big unfulfilled dance ambition?

I feel I haven’t achieved anything and that is why my life’s book still has commas, dashes and many continuing dots. So the search continues, maybe with dance, maybe without.

The expectations around you are high; do you feel the pressure?

Yes, at times it does, because I am not a demigod, I am only human. It’s hard to be objective when you yourself are the object. I often look at the audience from the wings before a performance and try to understand why they have come to watch me. I have never been able to answer that question, but I try to give my all to the observers when I perform hoping that, even if it was a passing moment, we had some level of exchange. That way, I also put a lot of pressure on myself.

How do you feel performing on stage?

I don’t have the words to describe it and that’s why I dance.

Your most memorable performance?

Performing in front of my gurus in Mumbai in India in 2016.

What has been your most memorable collaboration in dance?

Working with a living legend, Aditi Mangaldas, on Echoes, the solo she created on me. I idolise her – the way she moves, thinks, explores and talks. I felt that every second I spent with her was like a day in the university of life and dance. She is dance!

What advice would you give aspiring dancers?

Who am I to give advice? All I can say in simple terms is that there’s a reason you have come this far in life. Don’t give up, keep moving up.

What are your big passions away from dance?

Animals, gardening, decorating, eating, documentaries, walks in the countryside, history, reading books, talking, joking and laughing with my inner circle of friends. The list goes on.

Why do you love dance?

Who said I love dance?

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less